体外循环期间不同机械通气策略(CPBVENT 2014):随机对照试验研究方案
CPBVENT研究为单盲、多中心、随机对照试验,拟纳入870例择期体外循环心脏手术患者,随机分为体外循环期间无机械通气、持续气道正压5 cmH2O、以及呼吸频率5次/分且潮气量2-3 ml/kg理想体重加呼气末正压3-5 cmH2O三组,主要终点为重症监护室出院前PaO2/FiO2比值<200的发生率。
要点
- 体外循环期间维持机械通气对肺的保护作用证据薄弱,尚无公认的标准化肺保护策略。
- 研究比较三种通气策略对术后肺功能及并发症的影响,主要终点为ICU出院前PaO2/FiO2<200发生率。
- 次要终点为术后肺部并发症发生率和30天死亡率,随访至随机后12个月。
核心结论
- CPBVENT试验将确定体外循环期间不同通气策略是否以及如何影响心脏手术患者术后肺部并发症和结局。
研究设计与样本
- 单盲、多中心、随机对照试验,拟纳入870例择期心脏手术且计划使用体外循环的患者。
- 患者随机分为三组:体外循环期间无机械通气、持续气道正压5 cmH2O、呼吸频率5次/分且潮气量2-3 ml/kg理想体重加呼气末正压3-5 cmH2O。
主要发现
- 现有随机临床和动物试验少而小,提示体外循环期间维持机械通气对肺有保护作用,但证据来自替代和次要临床终点,主要限于择期冠状动脉手术,证据薄弱。
- 根据现有学术文献数据,尚不能推荐无可争议的体外循环期间标准化肺保护策略。
关键数值与推荐
- 主要终点:重症监护室出院前PaO2/FiO2比值<200的发生率。
- 次要终点:术后肺部并发症发生率和30天死亡率。
- 随访时间:随机分组后12个月。
- 试验注册:ClinicalTrials.gov,ID:NCT02090205,注册日期2014年3月8日。
局限性
- 现有证据薄弱,来自替代和次要临床终点,主要限于择期冠状动脉手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is no consensus on which lung-protective strategies should be used in cardiac surgery patients. Sparse and small randomized clinical and animal trials suggest that maintaining mechanical ventilation during cardiopulmonary bypass is protective on the lungs. Unfortunately, such evidence is weak as it comes from surrogate and minor clinical endpoints mainly limited to elective coronary surgery. According to the available data in the academic literature, an unquestionable standardized strategy of lung protection during cardiopulmonary bypass cannot be recommended. The purpose of the CPBVENT study is to investigate the effectiveness of different strategies of mechanical ventilation during cardiopulmonary bypass on postoperative pulmonary function and complications. METHODS/DESIGN: The CPBVENT study is a single-blind, multicenter, randomized controlled trial. We are going to enroll 870 patients undergoing elective cardiac surgery with planned use of cardiopulmonary bypass. Patients will be randomized into three groups: (1) no mechanical ventilation during cardiopulmonary bypass, (2) continuous positive airway pressure of 5 cmH2O during cardiopulmonary bypass, (3) respiratory rate of 5 acts/min with a tidal volume of 2-3 ml/Kg of ideal body weight and positive end-expiratory pressure of 3-5 cmH2O during cardiopulmonary bypass. The primary endpoint will be the incidence of a PaO2/FiO2 ratio <200 until the time of discharge from the intensive care unit. The secondary endpoints will be the incidence of postoperative pulmonary complications and 30-day mortality. Patients will be followed-up for 12 months after the date of randomization. DISCUSSION: The CPBVENT trial will establish whether, and how, different ventilator strategies during cardiopulmonary bypass will have an impact on postoperative pulmonary complications and outcomes of patients undergoing cardiac surgery. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02090205 . Registered on 8 March 2014.
引用
- Bignami E, Guarnieri M, Saglietti F, et al. Different strategies for mechanical VENTilation during CardioPulmonary Bypass (CPBVENT 2014): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28592276. doi:10.1186/s13063-017-2008-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。